Market access

Achieving market access goes beyond product approval. It encompasses a broad range of activities that demonstrate a product’s safety, efficacy and value to regulators, healthcare providers and patients. These include preparing Clinical Evaluation Reports (CER), submitting regulatory filings and ensuring all technical documentation is translated and localized according to national regulations.

For multilingual submissions, accurate and compliant translation is critical. Any inconsistency in terminology management, labeling or documentation can delay approval or restrict access to key markets. RWS supports market access by combining deep regulatory expertise with high-quality translation and localization services. Our teams work with subject-matter experts, linguists and compliance specialists to ensure every document – from clinical data to product labeling – meets linguistic and regulatory standards worldwide.